Palmitic Acid-Conjugated Radiopharmaceutical for Integrin α v β 3 -Targeted Radionuclide Therapy.
- Published in:
- Pharmaceutics, 2022, v. 14, n. 7, p. N.PAG, doi. 10.3390/pharmaceutics14071327
- By:
- Publication type:
- Article
Works by Luo, Chuangwei
Results: 4
1
2
A <sup>64</sup>Cu‐porphyrin‐based dual‐modal molecular probe with integrin α<sub>v</sub>β<sub>3</sub> targeting function for tumour imaging.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2020, v. 63, n. 5, p. 212, doi. 10.1002/jlcr.3833
- By:
- Publication type:
- Article
3
Nuclear imaging of PD-L1 expression promotes the synergistic antitumor efficacy of targeted radionuclide therapy and immune checkpoint blockade.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2025, v. 52, n. 3, p. 955, doi. 10.1007/s00259-024-06962-w
- By:
- Publication type:
- Article
4
A Dual pH-Responsive DOX-Encapsulated Liposome Combined with Glucose Administration Enhanced Therapeutic Efficacy of Chemotherapy for Cancer.
- Published in:
- International Journal of Nanomedicine, 2021, v. 16, p. 3185, doi. 10.2147/IJN.S303874
- By:
- Publication type:
- Article